RARS1 and graft versus host disease: Since IRX4204 preferentially activates RXR homodimers, the endogenous RA signaling pathway that is heightened in GVHD may be impaired in cGVHD mice due to the competitive binding of RXRs to the agonist or other receptors, reducing binding with RARs.